Beyond Treatment,
Towards Better Lives

Built on our proprietary NTIG® platform, we reduce treatment burden and achieve an optimal balance of efficacy and safety.

OUR VALUES

Our Values – 01

Aging
Society

Supporting healthier aging through safer and more sustainable long-term treatment approaches

Our Values – 02

Everyday
Convenience

Reducing treatment burden through long-acting and patient-friendly biologic medicines

Our Values – 03

Broader
Accessibility

Expanding access to advanced biologic therapies through scalable and cost-efficient innovation

Our Values – 04

Beyond Traditional
Boundaries

Developing biologic therapies designed for broader patient populations and real-world applicability
PLATFORM

Where biologics become long-acting multi-target medicines

NTIG® (Neo Tri-ImmunoGlobulin) is ProGen’s next-generation biologics platform engineered to move therapeutics beyond conventional limitations.
From metabolic disease to next-generation immunobiologics,
NTIG® expands what biologics can achieve.

com-icon-5-1
Sustained Signaling
Long-acting biologics engineered for durable pharmacologic activity
com-icon-5-2
Multi-target Flexibility
Modular architecture enabling multi-receptor and bispecific therapeutics
com-icon-5-3
Precision Fc Design
Non-cytolytic tri-immunoglobulin engineering optimized for stability and scalability
MEDIA

Latest News from Progen